These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 2296649)

  • 1. Pseudolayering of Gd-DTPA in the urinary bladder.
    Elster AD; Sobol WT; Hinson WH
    Radiology; 1990 Feb; 174(2):379-81. PubMed ID: 2296649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Oral contrast media for magnetic resonance tomography of the abdomen. III. Initial patient research with gadolinium-DTPA].
    Claussen C; Kornmesser W; Laniado M; Kaminsky S; Hamm B; Felix R
    Rofo; 1988 Jun; 148(6):683-9. PubMed ID: 2837806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preoperative staging of bladder carcinomas with Gd-DTPA-supported dynamic magnetic resonance tomography. Comparison with plain and Gd-DTPA-supported spin-echo sequences].
    Venz S; Hosten N; Ilg J; Mäurer J; Podrabsky P; Fedel M; Ebert T; Nagel R
    Rofo; 1996 Mar; 164(3):218-25. PubMed ID: 8672777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence.
    Reimer P; Rummeny EJ; Shamsi K; Balzer T; Daldrup HE; Tombach B; Hesse T; Berns T; Peters PE
    Radiology; 1996 Apr; 199(1):177-83. PubMed ID: 8633143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oral contrast media for the magnetic resonance tomography of the abdomen. A clinical trial of the tolerance for gadolinium-DTPA].
    Kaminsky S; Laniado M; Gogoll M; Kornmesser W; Clauss W; Felix R
    Rofo; 1992 Jan; 156(1):17-23. PubMed ID: 1733470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gd-DTPA as a contrast agent in CT.
    Bloem JL; Wondergem J
    Radiology; 1989 May; 171(2):578-9. PubMed ID: 2704827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gadolinium-DTPA as an oral contrast medium in magnetic resonance tomography].
    Kaminsky S; Laniado M; Gogoll M; Kornmesser W; Clauss W; Felix R
    Radiol Diagn (Berl); 1989; 30(5):541-8. PubMed ID: 2587719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gadolinium-DTPA as an oral contrast medium for magnetic resonance tomography of the pancreas].
    Neumann K; Kaminsky S; Gogoll M; Clauss W; Langer M; Felix R
    Rofo; 1991 Mar; 154(3):262-8. PubMed ID: 1849293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [MRT of bladder carcinoma: tumor staging and gadolinium contrast behavior].
    Doringer E; Joos H; Forstner R; Schmoller H
    Rofo; 1991 Apr; 154(4):357-63. PubMed ID: 1850149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The diagnosis of bladder carcinomas by NMR tomography: an improvement with Gd-DTPA?].
    Sparenberg A; Hamm B; Hammerer P; Samberger V; Wolf KJ
    Rofo; 1991 Aug; 155(2):117-22. PubMed ID: 1878537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of hydroxyethyl-starch-ferrioxamine as an intravascular MR contrast agent for assessment of myocardial perfusion.
    Tian G; Shen J; Su S; Kozlowski P; Sun J; Xiang B; Saunders JK; Deslauriers R
    Acta Radiol Suppl; 1997; 412():85-90. PubMed ID: 9240086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gadolinium-DTPA-enhanced MR imaging of spinal neoplasms: preliminary investigation and comparison with unenhanced spin-echo and STIR sequences.
    Stimac GK; Porter BA; Olson DO; Gerlach R; Genton M
    AJR Am J Roentgenol; 1988 Dec; 151(6):1185-92. PubMed ID: 3055895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary bladder neoplasms: evaluation with contrast-enhanced MR imaging.
    Neuerburg JM; Bohndorf K; Sohn M; Teufl F; Guenther RW; Daus HJ
    Radiology; 1989 Sep; 172(3):739-43. PubMed ID: 2772181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal bladder wall morphology in Gd-DTPA-enhanced clinical MR imaging using an endorectal surface coil and histological assessment of submucosal linear enhancement using [14C]Gd-DOTA autoradiography in an animal model.
    Takeda K; Kawaguchi T; Shiraishi T; Kobayashi S; Hayashi N; Yanagawa M; Tochigi H; Sakuma H; Kawamura J; Nakagawa T
    Eur J Radiol; 1998 Feb; 26(3):290-6. PubMed ID: 9587759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of Gadolinium-DTPA in the assessment of renal tumors with magnetic resonance].
    Torricelli P; Montanari N; De Santis M; Pollastri C
    Radiol Med; 1994 May; 87(5):653-61. PubMed ID: 8008898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The contribution of gadolinium to the magnetic resonance diagnosis of spondylodiscitis].
    Dalla Palma L; Pozzi-Mucelli R; Cova M; Iannis MR; Pagnan L
    Radiol Med; 1991 Oct; 82(4):393-400. PubMed ID: 1767043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic kinetics and magnetic resonance imaging of gadolinium ethoxybenzyl diethylenetriaminepentacetic acid (Gd-EOB-DTPA) in dogs.
    Benness G; Khangure M; Morris I; Warwick A; Burrows P
    Australas Radiol; 1993 Aug; 37(3):252-5. PubMed ID: 8373327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracranial lesions of the head and neck: preliminary experience with Gd-DTPA-enhanced MR imaging.
    Robinson JD; Crawford SC; Teresi LM; Schiller VL; Lufkin RB; Harnsberger HR; Dietrich RB; Crim JR; Duckwiler GR; Spickler EM
    Radiology; 1989 Jul; 172(1):165-70. PubMed ID: 2740499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.
    Vogl TJ; Kümmel S; Hammerstingl R; Schellenbeck M; Schumacher G; Balzer T; Schwarz W; Müller PK; Bechstein WO; Mack MG; Söllner O; Felix R
    Radiology; 1996 Jul; 200(1):59-67. PubMed ID: 8657946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-enhancing properties of Gd-DTPA at 2.0 Tesla.
    Schmiedl U; Moseley MM; Ogan MD; Chew WM; Brasch RC
    Radiat Med; 1987; 5(1):1-5. PubMed ID: 3628851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.